Skip to main content

Articles

Page 16 of 27

  1. Chronic traumatic encephalopathy (CTE) is a recently revived term used to describe a neurodegenerative process that occurs as a long term complication of repetitive mild traumatic brain injury (TBI). Corsellis...

    Authors: Sam Gandy, Milos D Ikonomovic, Effie Mitsis, Gregory Elder, Stephen T Ahlers, Jeffrey Barth, James R Stone and Steven T DeKosky
    Citation: Molecular Neurodegeneration 2014 9:37
  2. The ingestion of a high-fat diet (HFD) and the resulting obese state can exert a multitude of stressors on the individual including anxiety and cognitive dysfunction. Though many studies have shown that exerci...

    Authors: Silvia S Kang, Patricio R Jeraldo, Aishe Kurti, Margret E Berg Miller, Marc D Cook, Keith Whitlock, Nigel Goldenfeld, Jeffrey A Woods, Bryan A White, Nicholas Chia and John D Fryer
    Citation: Molecular Neurodegeneration 2014 9:36
  3. The 5XFAD early onset mouse model of Alzheimer’s disease (AD) is gaining momentum. Behavioral, electrophysiological and anatomical studies have identified age-dependent alterations that can be reminiscent of h...

    Authors: Véréna Landel, Kévin Baranger, Isabelle Virard, Béatrice Loriod, Michel Khrestchatisky, Santiago Rivera, Philippe Benech and François Féron
    Citation: Molecular Neurodegeneration 2014 9:33
  4. Although genome wide studies have associated single nucleotide polymorphisms (SNP)s near PICALM with Alzheimer’s disease (AD), the mechanism underlying this association is unclear. PICALM is involved in clathrin-...

    Authors: Ishita Parikh, Christopher Medway, Steven Younkin, David W Fardo and Steven Estus
    Citation: Molecular Neurodegeneration 2014 9:32
  5. Intracellular protein trafficking plays an important role in neuronal function and survival. Protein misfolding is a common theme found in many neurodegenerative diseases, and intracellular trafficking machine...

    Authors: Xin Wang, Timothy Huang, Guojun Bu and Huaxi Xu
    Citation: Molecular Neurodegeneration 2014 9:31
  6. We recently found that brain tissue from patients with type-2 diabetes (T2D) and cognitive impairment contains deposits of amylin, an amyloidogenic hormone synthesized and co-secreted with insulin by pancreati...

    Authors: Sarah Srodulski, Savita Sharma, Adam B Bachstetter, Jennifer M Brelsfoard, Conrado Pascual, Xinmin Simon Xie, Kathryn E Saatman, Linda J Van Eldik and Florin Despa
    Citation: Molecular Neurodegeneration 2014 9:30
  7. We recently reported that Parkinsonian and dementia phenotypes emerge between 7-12 months of age in tau-/- mice on a Bl6/129sv mixed background. These observations were partially replicated by another group using...

    Authors: Peng Lei, Scott Ayton, Steve Moon, Qihao Zhang, Irene Volitakis, David I Finkelstein and Ashley I Bush
    Citation: Molecular Neurodegeneration 2014 9:29
  8. Accumulation and deposition of β-amyloid peptides (Aβ) in the brain is a central event in the pathogenesis of Alzheimer’s disease (AD). Besides the parenchymal pathology, Aβ is known to undergo active transpor...

    Authors: Hongmei Li, Qinxi Guo, Taeko Inoue, Vinicia A Polito, Katsuhiko Tabuchi, Robert E Hammer, Robia G Pautler, George E Taffet and Hui Zheng
    Citation: Molecular Neurodegeneration 2014 9:28
  9. The substantia nigra (SN) midbrain nucleus is constitutively iron rich. Iron levels elevate further with age, and pathologically in Parkinson’s disease (PD). Iron accumulation in PD SN involves dysfunction of ...

    Authors: Scott Ayton, Peng Lei, Paul A Adlard, Irene Volitakis, Robert A Cherny, Ashley I Bush and David I Finkelstein
    Citation: Molecular Neurodegeneration 2014 9:27
  10. A thorough investigation of the neurobiology of HIV-induced neuronal dysfunction and its evolving phenotype in the setting of viral suppression has been limited by the lack of validated small animal models to ...

    Authors: Vez Repunte-Canonigo, Celine Lefebvre, Olivier George, Tomoya Kawamura, Marisela Morales, George F Koob, Andrea Califano, Eliezer Masliah and Pietro Paolo Sanna
    Citation: Molecular Neurodegeneration 2014 9:26
  11. Experimental evidence has demonstrated that several aspects of adult neural stem cells (NSCs), including their quiescence, proliferation, fate specification and differentiation, are regulated by epigenetic mec...

    Authors: Carlos P Fitzsimons, Emma van Bodegraven, Marijn Schouten, Roy Lardenoije, Konstantinos Kompotis, Gunter Kenis, Mark van den Hurk, Marco P Boks, Caroline Biojone, Samia Joca, Harry WM Steinbusch, Katie Lunnon, Diego F Mastroeni, Jonathan Mill, Paul J Lucassen, Paul D Coleman…
    Citation: Molecular Neurodegeneration 2014 9:25
  12. Intraneuronal inclusions of TAR DNA-binding protein 43 (TDP-43) have been found in the majority of Amyotrophic Lateral Sclerosis (ALS) patients. Mutations in the gene encoding TDP-43 cause familial ALS. Transg...

    Authors: Sarah Herdewyn, Carla Cirillo, Ludo Van Den Bosch, Wim Robberecht, Pieter Vanden Berghe and Philip Van Damme
    Citation: Molecular Neurodegeneration 2014 9:24
  13. Parkinson’s disease (PD) is the most common movement neurodegenerative movement disorder. An incomplete understanding of the molecular pathways involved in its pathogenesis impedes the development of effective...

    Authors: Radek Linhart, Sarah Anne Wong, Jieyun Cao, Melody Tran, Anne Huynh, Casey Ardrey, Jong Min Park, Christine Hsu, Saher Taha, Rentia Peterson, Shannon Shea, Jason Kurian and Katerina Venderova
    Citation: Molecular Neurodegeneration 2014 9:23
  14. Alzheimer’s disease (AD) is the leading cause of dementia affecting greater than 26 million people worldwide. Although cerebrospinal fluid (CSF) levels of Aβ42, tau, and p-tau181 are well established as diagnosti...

    Authors: Kristin R Wildsmith, Stephen P Schauer, Ashley M Smith, David Arnott, Yuda Zhu, Joshua Haznedar, Surinder Kaur, W Rodney Mathews and Lee A Honigberg
    Citation: Molecular Neurodegeneration 2014 9:22
  15. Recent genome-wide association studies linked variants in TREM2 to a strong increase in the odds of developing Alzheimer’s disease. The mechanism by which TREM2 influences the susceptibility to Alzheimer’s diseas...

    Authors: Jason D Ulrich, Mary Beth Finn, Yaming Wang, Alice Shen, Thomas E Mahan, Hong Jiang, Floy R Stewart, Laura Piccio, Marco Colonna and David M Holtzman
    Citation: Molecular Neurodegeneration 2014 9:20
  16. Imaging methods are used widely to understand structure of brain and other biological objects. However, sample penetration by light microscopy is limited due to light scattering by the tissue. A number of meth...

    Authors: Ekaterina Poguzhelskaya, Dmitry Artamonov, Anastasia Bolshakova, Olga Vlasova and Ilya Bezprozvanny
    Citation: Molecular Neurodegeneration 2014 9:19
  17. In dementia with Lewy bodies (DLB) abnormal interactions between α-synuclein (α-syn) and beta amyloid (Aβ) result in selective degeneration of neurons in the neocortex, limbic system and striatum. However, fac...

    Authors: Cassia R Overk, Anna Cartier, Gideon Shaked, Edward Rockenstein, Kiren Ubhi, Brian Spencer, Diana L Price, Christina Patrick, Paula Desplats and Eliezer Masliah
    Citation: Molecular Neurodegeneration 2014 9:18
  18. 6-hydroxydopamine (6-OHDA) is one of the most commonly used toxins for modeling degeneration of dopaminergic (DA) neurons in Parkinson's disease. 6-OHDA also causes axonal degeneration, a process that appears ...

    Authors: Xi Lu, Jeong Sook Kim-Han, Steve Harmon, Shelly E Sakiyama-Elbert and Karen L O'Malley
    Citation: Molecular Neurodegeneration 2014 9:17
  19. The role of mitochondrial dysfunction has long been implicated in age-related brain pathology, including Alzheimer’s disease (AD). However, the mechanism by which mitochondrial dysfunction may cause neurodegen...

    Authors: Lokesh Kukreja, Gregory C Kujoth, Tomas A Prolla, Fred Van Leuven and Robert Vassar
    Citation: Molecular Neurodegeneration 2014 9:16
  20. We recently identified U1 small nuclear ribonucleoprotein (snRNP) tangle-like aggregates and RNA splicing abnormalities in sporadic Alzheimer’s disease (AD). However little is known about snRNP biology in earl...

    Authors: Chadwick M Hales, Nicholas T Seyfried, Eric B Dammer, Duc Duong, Hong Yi, Marla Gearing, Juan C Troncoso, Elliott J Mufson, Madhav Thambisetty, Allan I Levey and James J Lah
    Citation: Molecular Neurodegeneration 2014 9:15
  21. Central nervous system (CNS) trauma and neurodegenerative disorders trigger a cascade of cellular and molecular events resulting in neuronal apoptosis and regenerative failure. The pathogenic mechanisms and ge...

    Authors: Tasneem P Sharma, Colleen M McDowell, Yang Liu, Alex H Wagner, David Thole, Benjamin P Faga, Robert J Wordinger, Terry A Braun and Abbot F Clark
    Citation: Molecular Neurodegeneration 2014 9:14
  22. According to the modified amyloid hypothesis the main event in the pathogenesis of Alzheimer’s disease (AD) is the deposition of neurotoxic amyloid β-peptide (Aβ) within neurons. Additionally to full-length pe...

    Authors: Erika Avendaño Guzmán, Yvonne Bouter, Bernhard C Richard, Lars Lannfelt, Martin Ingelsson, Anders Paetau, Auli Verkkoniemi-Ahola, Oliver Wirths and Thomas A Bayer
    Citation: Molecular Neurodegeneration 2014 9:13
  23. Authors: Virginia Fonte, Vishantie Dostal, Christine M Roberts, Patrick Gonzales, Pascale N Lacor, Pauline T Velasco, Jordi Magrane, Natalie Dingwell, Emily Y Fan, Michael A Silverman, Gretchen H Stein and Christopher D Link
    Citation: Molecular Neurodegeneration 2014 9:12

    The original article was published in Molecular Neurodegeneration 2011 6:61

  24. The editors of Molecular Neurodegeneration would like to thank all the reviewers who have contributed to the journal in Volume 8 (2013).

    Authors: Guojun Bu and Huaxi Xu
    Citation: Molecular Neurodegeneration 2014 9:9
  25. Recent genome-wide association studies (GWAS) of late-onset Alzheimer’s disease (LOAD) have identified single nucleotide polymorphisms (SNPs) which show significant association at the well-known APOE locus and at...

    Authors: Christopher W Medway, Samer Abdul-Hay, Tynickwa Mims, Li Ma, Gina Bisceglio, Fanggeng Zou, Shane Pankratz, Sigrid B Sando, Jan O Aasly, Maria Barcikowska, Joanna Siuda, Zbigniew K Wszolek, Owen A Ross, Minerva Carrasquillo, Dennis W Dickson, Neill Graff-Radford…
    Citation: Molecular Neurodegeneration 2014 9:11
  26. Identification and quantification of fibrillar amyloid in brain using positron emission tomography (PET) imaging and Amyvid™ ([18 F] Amyvid, [18 F] florbetapir, 18 F-AV-45) was recently approved by the US Food an...

    Authors: Effie M Mitsis, Heidi A Bender, Lale Kostakoglu, Josef Machac, Jane Martin, Jennifer L Woehr, Margaret C Sewell, Amy Aloysi, Martin A Goldstein, Clara Li, Mary Sano and Sam Gandy
    Citation: Molecular Neurodegeneration 2014 9:10
  27. Cross-breeding of transgenic mice is commonly used to assess gene-gene interactions, particularly in the context of disease. Strain background changes can influence the phenotype of mouse models and can confou...

    Authors: Rachel M Bailey, John Howard, Joshua Knight, Naruhiko Sahara, Dennis W Dickson and Jada Lewis
    Citation: Molecular Neurodegeneration 2014 9:8
  28. Amyloid-β peptide ending at 42nd residue (Aβ42) is believed as a pathogenic peptide for Alzheimer disease. Although γ-secretase is a responsible protease to generate Aβ through a processive cleavage, the prote...

    Authors: Yu Ohki, Naoaki Shimada, Aya Tominaga, Satoko Osawa, Takuya Higo, Satoshi Yokoshima, Tohru Fukuyama, Taisuke Tomita and Takeshi Iwatsubo
    Citation: Molecular Neurodegeneration 2014 9:7
  29. The β-amyloid (Aβ) peptide has been postulated to be a key determinant in the pathogenesis of Alzheimer’s disease (AD). Aβ is produced through sequential cleavage of the β-amyloid precursor protein (APP) by β-...

    Authors: Shangtong Jiang, Yanfang Li, Xian Zhang, Guojun Bu, Huaxi Xu and Yun-wu Zhang
    Citation: Molecular Neurodegeneration 2014 9:6
  30. Familial British and Familial Danish dementias (FBD and FDD, respectively) are associated with mutations in the BRI2 gene. Processing of the mutated BRI2 protein leads to the accumulation in the brain of the 34-m...

    Authors: María S Marcora, Agata C Fernández-Gamba, Luz A Avendaño, Cecilia Rotondaro, Osvaldo L Podhajcer, Rubén Vidal, Laura Morelli, María F Ceriani and Eduardo M Castaño
    Citation: Molecular Neurodegeneration 2014 9:5
  31. Although BACE1 is a major therapeutic target for Alzheimer’s disease (AD), potential side effects of BACE1 inhibition are not well characterized. BACE1 cleaves over 60 putative substrates, however the majority...

    Authors: Vivek Gautam, Carla D’Avanzo, Matthias Hebisch, Dora M Kovacs and Doo Yeon Kim
    Citation: Molecular Neurodegeneration 2014 9:4
  32. An early substantial loss of basal forebrain cholinergic neurons (BFCNs) is a constant feature of Alzheimer’s disease (AD) and is associated with deficits in spatial learning and memory. Induced pluripotent st...

    Authors: Lishu Duan, Bula J Bhattacharyya, Abdelhak Belmadani, Liuliu Pan, Richard J Miller and John A Kessler
    Citation: Molecular Neurodegeneration 2014 9:3
  33. The APOE4 allele of apolipoprotein E (apoE) is the greatest genetic risk factor for Alzheimer’s disease (AD) compared to APOE2 and APOE3. Amyloid-β (Aβ), particularly in a soluble oligomeric form (oAβ), is consid...

    Authors: Leon M Tai, Shipra Mehra, Varsha Shete, Steve Estus, G William Rebeck, Guojun Bu and Mary Jo LaDu
    Citation: Molecular Neurodegeneration 2014 9:2
  34. BACE1 is one of the two enzymes that cleave amyloid precursor protein to generate Alzheimer's disease (AD) beta amyloid peptides. It is widely believed that BACE1 initiates APP processing in endosomes, and in ...

    Authors: Virginie Buggia-Prévot, Celia G Fernandez, Sean Riordan, Kulandaivelu S Vetrivel, Jelita Roseman, Jack Waters, Vytautas P Bindokas, Robert Vassar and Gopal Thinakaran
    Citation: Molecular Neurodegeneration 2014 9:1
  35. The high affinity tyrosine kinase receptor, TrkB, is the primary receptor for brain derived neurotrophic factor (BDNF) and plays an important role in development, maintenance and plasticity of the striatal out...

    Authors: Ellen M Unterwald, Michelle E Page, Timothy B Brown, Jonathan S Miller, Marta Ruiz, Karen A Pescatore, Baoji Xu, Louis French Reichardt, Joel Beverley, Bin Tang, Heinz Steiner, Elizabeth A Thomas and Michelle E Ehrlich
    Citation: Molecular Neurodegeneration 2013 8:47
  36. Mutations in the gene encoding superoxide dismutase 1 (SOD1) account for about 20% of the cases of familial amyotrophic lateral sclerosis (fALS). It is well established that mutations in SOD1, associated with ...

    Authors: David A Qualls, Mercedes Prudencio, Brittany LT Roberts, Keith Crosby, Hilda Brown and David R Borchelt
    Citation: Molecular Neurodegeneration 2013 8:46
  37. Mitochondrial impairment has been implicated in the pathogenesis of Huntington’s disease (HD). However, how mutant huntingtin impairs mitochondrial function and thus contributes to HD has not been fully elucid...

    Authors: Rodrigo A Quintanilla, Youngnam N Jin, Rommy von Bernhardi and Gail VW Johnson
    Citation: Molecular Neurodegeneration 2013 8:45
  38. Alpha-synuclein is a key protein implicated in the pathogenesis of Parkinson's disease (PD). It is the main component of the Lewy bodies, a cardinal neuropathological feature in the disease. In addition, whole...

    Authors: Marusela Oliveras-Salvá, Anke Van der Perren, Nicolas Casadei, Stijn Stroobants, Silke Nuber, Rudi D’Hooge, Chris Van den Haute and Veerle Baekelandt
    Citation: Molecular Neurodegeneration 2013 8:44
  39. Mutations in the Cu/Zn superoxide dismutase gene (SOD1) are responsible for 20% of familial forms of amyotrophic lateral sclerosis (ALS), and mutant SOD1 has been shown to have increased surface hydrophobicity in...

    Authors: Pei-Yi Lin, Sharotka M Simon, Won Kyun Koh, Oluwarotimi Folorunso, C Samuel Umbaugh and Anson Pierce
    Citation: Molecular Neurodegeneration 2013 8:43
  40. Spinocerebellar ataxia type 7 (SCA7) is caused by a toxic polyglutamine (polyQ) expansion in the N-terminus of the protein ataxin-7. Ataxin-7 has a known function in the histone acetylase complex, Spt/Ada/Gcn5...

    Authors: Carlotta E Duncan, Mahru C An, Theodora Papanikolaou, Caitlin Rugani, Cathy Vitelli and Lisa M Ellerby
    Citation: Molecular Neurodegeneration 2013 8:42
  41. Alzheimer’s disease (AD) is the most common form of dementia. At the diagnostic stage, the AD brain is characterized by the accumulation of extracellular amyloid plaques, intracellular neurofibrillary tangles ...

    Authors: Sonia Do Carmo and A Claudio Cuello
    Citation: Molecular Neurodegeneration 2013 8:37
  42. The aging process correlates with a progressive failure in the normal cellular and organ functioning; these alterations are aggravated in Alzheimer’s disease (AD). In both aging and AD there is a general decre...

    Authors: Fernanda Marques, João Carlos Sousa, Nuno Sousa and Joana Almeida Palha
    Citation: Molecular Neurodegeneration 2013 8:38
  43. Alzheimer’s disease (AD) is the most common form of dementia, afflicting more than 30 million people worldwide. Currently, there is no cure or way to prevent this devastating disease. Extracellular plaques, co...

    Authors: Cynthia A Lemere
    Citation: Molecular Neurodegeneration 2013 8:36
  44. Alzheimer’s disease (AD) is neuropathologically characterized by the combined occurrence of extracellular β-amyloid plaques and intracellular neurofibrillary tangles in the brain. While plaques contain aggrega...

    Authors: Jochen Walter and Gerhild van Echten-Deckert
    Citation: Molecular Neurodegeneration 2013 8:34
  45. Alzheimer’s disease (AD) is characterized by progressive memory loss and impaired cognitive function. Early-onset familial forms of the disease (FAD) are caused by inheritance of mutant genes encoding presenil...

    Authors: Karthikeyan Veeraraghavalu, Se Hoon Choi, Xiaoqiong Zhang and Sangram S Sisodia
    Citation: Molecular Neurodegeneration 2013 8:41
  46. Increasing evidence indicates that neuroinflammation is a critical factor contributing to the progression of various neurodegenerative diseases. The IKK/NF-κB signalling system is a central regulator of inflam...

    Authors: Ayesha Maqbool, Michael Lattke, Thomas Wirth and Bernd Baumann
    Citation: Molecular Neurodegeneration 2013 8:40